Abstract: A manufacturing method of an electrostatic charge image developing toner includes aggregating particles including binder resin particles in a dispersion to form aggregated particles and fusing the aggregated particles by heating the aggregated particles to raise a temperature, in which an agitating Reynolds number in agitation of the dispersion during the fusing is 5.0×104 or more and 1.0×106 or less.

Abstract: A manufacturing method of an electrostatic charge image developing toner includes aggregating particles including binder resin particles in a dispersion to form aggregated particles and heating the aggregated particles to raise a temperature of the aggregated particles and fuse the aggregated particles, in which, in the fusing, after raising the temperature to equal to or higher than a glass transition temperature of a binder resin in the binder resin particles, while agitating a dispersion containing the aggregated particles, an agitating rotation speed in the agitation of the dispersion is decreased in a stepwise manner or in a continuous manner.

Abstract: A manufacturing method of an electrostatic charge image developing toner includes a step of aggregating particles including binder resin particles and release agent particles in a dispersion to form aggregated particles and fusing the aggregated particles by heating the aggregated particles to raise a temperature, in which, in the fusing, an agitation equipment equipped with a rotating shaft and an agitating blade is used, a diameter d (m) of the agitating blade is 0.2 m or more, and in a case where, in the fusing, a circumferential speed of the agitating blade is denoted by u (m/s), a density of the dispersion is denoted by ? (kg/m3), an inner diameter of a granulating container is denoted by D (m), and a temperature of the dispersion is denoted by T (° C.), a value of ?ud/DT is 1 or more and 40 or less.

Abstract: Saltiness enhancers containing cyclotene as an active ingredient can effectively enhance the saltiness of a sodium chloride-containing food.

Abstract: An awakening degree detecting device outputs awakening degree information corresponding to an awakening degree of a driver of a vehicle. A stimulus providing device provides the driver with a stimulus including at least one of a vibration stimulus imparting vibration and an apparent motion stimulus giving an illusion of motion presence. A control device outputs, based on the awakening degree information, a first control signal causing the stimulus providing device to provide the stimulus in a case where the awakening degree is less than a first threshold, and to output a second control signal causing the stimulus providing device to provide the stimulus after the first control signal is outputted.

Abstract: Flavoring compositions containing at least two compounds selected from the group consisting of (A) a compound represented by the formula (I): wherein each symbol is as defined in the present specification, (B) ?-caryophyllene oxide, and (C) a compound represented by the formula (II): wherein each symbol is as defined in the present specification, are useful for effectively enhancing a mouth-coating feel and the like.

Abstract: An in-oil-heated substance of cyclotene, an in-oil-heated substance of a cyclotene analogous compound, or an in-oil-heated substance of a substance capable of producing cyclotene or a cyclotene analogous compound by heating are effective as mouth-coating feel enhancers.

Abstract: An awakening degree detecting device outputs awakening degree information corresponding to an awakening degree of a driver of a vehicle. A stimulus providing device provides the driver with a stimulus including at least one of a vibration stimulus imparting vibration and an apparent motion stimulus giving an illusion of motion presence. A control device outputs, based on the awakening degree information, a first control signal causing the stimulus providing device to provide the stimulus in a case where the awakening degree is less than a first threshold, and to output a second control signal causing the stimulus providing device to provide the stimulus after the first control signal is outputted.

Abstract: [Object] To maintain a wakefulness state of a target more effectively. [Solution] Provided is an wakefulness maintenance device including: a stimulus provision section configured to provide a vibratory stimulus to at least a part of a body of a target; and a control section configured to control a provision mode and whether or not the stimulus provision section provides the vibratory stimulus, on the basis of an estimated degree of wakefulness of the target. The stimulus provision section includes a contact section configured to come into contact with the part of the body of the target, and a plurality of stimulus generation sections configured to be installed in the contact section and generate the vibratory stimuli under the control of the control section.

Abstract: An application operation evaluating apparatus, includes a detecting unit that detects pressing force obtained by a plurality of sensors provided at an application target surface in accordance with an application operation to the application target surface; an estimating unit that estimates a pressed position of the application operation on the application target surface based on pressing forces respectively applied to the sensors obtained by the detecting unit; a load distribution generating unit that generates load distribution in accordance with the application operation based on the pressing force obtained by the detecting unit and the pressed position obtained by the estimating unit; and a display unit that displays the load distribution obtained by the load distribution generating unit on a screen.

Abstract: An application operation evaluating apparatus, includes a detecting unit that detects pressing force obtained by a plurality of sensors provided at an application target surface in accordance with an application operation to the application target surface; an estimating unit that estimates a pressed position of the application operation on the application target surface based on pressing forces respectively applied to the sensors obtained by the detecting unit; a load distribution generating unit that generates load distribution in accordance with the application operation based on the pressing force obtained by the detecting unit and the pressed position obtained by the estimating unit; and a display unit that displays the load distribution obtained by the load distribution generating unit on a screen.

Abstract: An evaluation method for evaluating the ultraviolet protection effect of a measurement sample applied on a substrate includes measuring, at predetermined wavelength intervals, a change over time of a spectral transmission spectrum of the measurement sample within a predetermined wavelength range by irradiating light from a light source that includes ultraviolet light, visible light, and infrared light under a predetermined irradiation condition; establishing, based on the change over time of the spectral transmission spectrum, a correlation between a light irradiation time and an erythema effective dose per unit time, which is obtained by dividing an erythema effective dose of the measurement sample by an erythema effective dose per 1 MED; and calculating an in vitro rSPF predictive value for the measurement sample on the basis of a time until a cumulative erythema effective dose, which is obtained through time integration based on the correlation, reaches 1 MED.

Abstract: An evaluation method for evaluating the ultraviolet protection effect of a measurement sample applied on a substrate includes a first step of measuring, at predetermined wavelength intervals, a change over time of a spectral transmission spectrum of the measurement sample within a predetermined wavelength range by irradiating light from a light source that includes ultraviolet light, visible light, and infrared light under a predetermined irradiation condition; a second step of establishing, based on the change over time of the spectral transmission spectrum, a correlation between a light irradiation time and an erythema effective dose per unit time, which is obtained by dividing an erythema effective dose of the measurement sample by an erythema effective dose per 1 MED; and a third step of calculating an in vitro rSPF predictive value for the measurement sample on the basis of a time until a cumulative erythema effective dose, which is obtained through time integration based on the correlation, reaches 1 ME

Abstract: A skin substitute membrane includes a surface on one side including a groove-shaped depressed portion and a planar portion, the depressed portion having a cross section having a chamfered V-letter shape, the surface having an arithmetic mean roughness Sa of more than or equal to 10 ?m to less than or equal to 50 ?m. The depressed portion has a width of more than or equal to 50 ?m to less than or equal to 500 ?m and a depth of more than or equal to 30 ?m to less than or equal to 150 ?m. A spectral transmittance for light of more than or equal to 290 nm to less than or equal to 400 nm in wavelength is more than or equal to 50% and less than or equal to 100%.

Abstract: A skin substitute membrane includes a surface on one side including a groove-shaped depressed portion and a planar portion, the depressed portion having a cross section having a chamfered V-letter shape, the surface having an arithmetic mean roughness Sa of more than or equal to 10 ?m to less than or equal to 50 ?m. The depressed portion has a width of more than or equal to 50 ?m to less than or equal to 500 ?m and a depth of more than or equal to 30 ?m to less than or equal to 150 ?m. A spectral transmittance for light of more than or equal to 290 nm to less than or equal to 400 nm in wavelength is more than or equal to 50% and less than or equal to 100%.

Abstract: A first step of measuring a change over time in the spectral transmission spectrum of a measurement sample by its exposure to the light of a light source including an ultraviolet radiation for a preset light exposure time, a second step of performing a correction according to the change over time in the spectral transmission spectrum of the measurement sample based on the result of the measurement obtained by the first step, and a third step of calculating the final in vitro predicted SPF of the measurement sample using the result of the correction obtained by the second step are included.

Abstract: A method of applying an external dermatological medication to a skin or a skin substitute substrate with an external dermatological medication for evaluating characteristics of the external dermatological medication acquired by irradiating the skin or the skin substitute substrate with light including a first applying step of spreading the external dermatological medication in one direction on the skin or the skin substitute substrate from a side surface of the skin or the skin substitute substrate; a second applying step of spreading the external dermatological medication in a direction perpendicular to the one direction on the skin or the skin substitute substrate, wherein the first applying step and the second applying step are repeated by a predetermined number of times.

Abstract: An ultraviolet radiation detector 10, detecting an ultraviolet radiation transmitted through or reflected from a measurement sample 15 from a light beam including at least the ultraviolet radiation, is characterized by spectral means 19 for spectrally splitting the ultraviolet radiation from the light beam and photodetection means 20 for detecting the ultraviolet radiation spectrally split by the spectral means 19, the photodetection means 20 including a photoelectric surface detecting only the ultraviolet radiation and formed of an element selected from In, Ga, N, Al, O and Cs.

Abstract: A method and apparatus for evaluating an ultraviolet radiation protection effect in a measurement sample is used for evaluating SPF (Sun Protection Factor). First, a temporal change of the spectral transmission spectrum in the measurement sample within a predetermined light wavelength range at predetermined wavelength intervals is measured. Second, a correlation between a light irradiating time and minimal erythema doses by predetermined lime intervals based on the temporal change of the spectral transmission spectrum is set. Third a predicted in vitro SPF in the measurement sample using a time until an accumulated minimal erythema dose that is obtained as a time integration of the minimal erythema doses based on the correlation obtained in the second step reaches 1 MED (Minimum Erythema Dose) is calculated.

Abstract: A skin substitute membrane includes a surface on one side including a groove-shaped depressed portion and a planar portion, the depressed portion having a cross section having a chamfered V-letter shape, the surface having an arithmetic mean roughness Sa of more than or equal to 10 ?m to less than or equal to 50 ?m. The depressed portion has a width of more than or equal to 50 ?m to less than or equal to 500 ?m and a depth of more than or equal to 30 ?m to less than or equal to 150 ?m. A spectral transmittance for light of more than or equal to 290 nm to less than or equal to 400 nm in wavelength is more than or equal to 50% and less than or equal to 100%.